## Rollout `ctl4`
- outcome: submitted
- turns: 5; cost: $0.263; submitted: True

### Turn 1  (stop_reason=tool_use)
- edgar_search({"search_query": "Snap Inc convertible notes dilutive shares December 31, 2024 maximum", "start_date": "2025-01-01", "end_date": "2025-04-07"})
  result: {"total_matching_documents": 102, "page": 1, "results": [{"form": "10-K", "file_date": "2025-02-05", "period_ending": "2024-12-31", "company": "Snap Inc  (SNAP)  (CIK 0001564408)", "ciks": ["0001564408"], "accession": "0001564408-25-000019", "document": "snap-20241231.htm", "description": "10-K", "url": "https://www.sec.gov/Archives/edgar/data/1564408/000156440825000019/snap-20241231.htm"}, {"form": "S-1/A", "file_date": "2025-04-04", "period_ending": null, "company": "Coeptis Therapeutics Holdings, Inc.  (COEP, COEPW)  (CIK 0001759186)", "ciks": ["0001759186"], "accession": "0001683168-25-002278", "document": "coeptis-s1a2.htm", "description": "AMENDMENT #2 TO FORM S-1", "url": "https://www.sec.gov/Archives/edgar/data/1759186/000168316825002278/coeptis-s1a2.htm"}, {"form": "424B3", "file_date": "2025-04-02", "period_ending": null, "company": "Coeptis Therapeutics Holdings, Inc.  (COEP, COEPW)  (CIK 0001759186)", "ciks": ["0001759186"], "accession": "0001683168-25-002228", "document": "coeptis_424b3-333269782.htm", "description": "PROSPECTUS", "url": "https://www.sec.gov/Archives/edgar/data/1759186/000168316825002228/coeptis_424b3-333269782.htm"}, {"form": "10-K", "file_date": "2025-03-28", "period_ending": "2024-12-31", "company": "Coeptis Therapeutics Holdings, Inc.  (COEP, COEPW)  (CIK 0001759186)", "ciks": ["0001759186"], "accession": "0001683168-25-001942", "document": "coeptis_i10k-123124.htm", "description": "FORM 10-K FOR DEC 2024", "url": "https://www.sec.gov/Archives/edgar/data/1759186/000168316825001942/coeptis_i10k-123124.htm"}, {"form": "424B3", "file_date": "2025-04-02", "period_ending": null, "company": "Coeptis Therapeutics Holdings, Inc.  (COEP, COEPW)  (CIK 0001759186)", "ciks": ["0001759186"], "accession": "0001683168-25-002229", "document": "coeptis_
  …[truncated 5,562 chars]

### Turn 2  (stop_reason=tool_use)
- parse_html_page({"url": "https://www.sec.gov/Archives/edgar/data/1564408/000156440825000019/snap-20241231.htm", "key": "snap10k"})
  result: SUCCESS: The result has been saved to the data storage under the key: snap10k. (614,017 characters)
  The data_storage currently contains the following keys:
  snap10k
  

### Turn 3  (stop_reason=tool_use)
- retrieve_information({"prompt": "From this Snap Inc 10-K document: {{snap10k}}, find the discussion of convertible notes and anti-dilutive / dilutive securities in the net income (loss) per share note. Specifically, find the maximum number of shares issuable upon conversion of the 2025 Notes, 2026 Notes (0.00% / 0.25% / etc.) as of December 31, 2024, the table of potentially dilutive securities excluded from diluted EPS, and any statement about the maximum dilutive impact of the convertible notes. Quote the exact figures and their context."})
  result: ## Net Loss per Share (Note 3): Convertible Notes and Anti-Dilutive Securities
  
  **Important correction:** The 2025 Notes carry a 0.25% coupon and the 2026 Notes carry a 0.75% coupon. The "0.00%" figure you mentioned does not appear for these notes. (The 2027 Notes do not bear regular interest, and the 2028 Notes carry 0.125%.)
  
  ### 1. Share count for the 2025 and 2026 Notes
  
  Note 3 does not state a per-series share count. It only describes the method:
  
  > "We use the if-converted method for calculating any potential dilutive effect of the convertible senior notes due in 2025, 2026, 2027, 2028, and 2030 (collectively, the 'Convertible Notes') on diluted net loss per share. The Convertible Notes would have a dilutive impact on net income per share when the average market price of Class A common stock for a given period exceeds the respective conversion price of the Convertible Notes."
  
  The per-series figures come from Note 7, which gives the conversion rates and principal outstanding as of December 31, 2024:
  
  - **2025 Notes:** 46.1233 shares per $1,000 principal, conversion price of approximately $21.68, principal outstanding of $36.2 million. Implied maximum shares ≈ **1.67 million**.
  - **2026 Notes:** 43.8481 shares per $1,000 principal, conversion price of approximately $22.81, principal outstanding of $249.8 million. Implied maximum shares ≈ **10.95 million**.
  
  These are my calculations (principal × conversion rate), not figures stated in the filing.
  
  For reference, the total for all five series ties to the Note 3 table:
  
  | Series | Implied shares (thousands) |
  |---|---|
  | 2025 Notes | ~1,672 |
  | 2026 Notes | ~10,950 |
  | 2027 Notes | ~12,885 |
  | 2028 Notes | ~26,624 |
  | 2030 Notes | ~33,814 |
  | **Total** | **~85,945** |
  
  The total matches the filing's 85,945 thousand s
  …[truncated 1,951 chars]

### Turn 4  (stop_reason=tool_use)
- retrieve_information({"prompt": "Quote exactly from this document {{snap10k}} the following: (1) the sentence and table in the net loss per share note listing potentially dilutive shares excluded (Convertible Notes row, 85,945 as of Dec 31 2024); (2) the Convertible Notes table in the debt note showing for each series (2025, 2026, 2027, 2028, 2030 Notes) the interest rate, principal outstanding, conversion rate per $1,000, and conversion price as of December 31, 2024; (3) any statement of maximum shares issuable upon conversion of the convertible notes."})
  result: Here are the passages from the document. The document does not contain a single table with interest rate, conversion rate, and conversion price for each series. Those terms appear in the narrative paragraphs of Note 7, which I've quoted below. The document also does not state a maximum number of shares issuable on conversion, so I've noted that at the end.
  
  **1. Net loss per share note (Note 3)**
  
  > For the periods presented, our potentially dilutive shares relating to stock options, RSUs, RSAs, and Convertible Notes were not included in the computation of diluted net loss per share as the effect of including these shares in the calculation would have been anti-dilutive.
  
  > The following potentially dilutive shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive:
  >
  > As of December 31, | 2024 | 2023 | 2022
  > (in thousands) | | |
  > Stock options | 680 | 1,697 | 3,159
  > Unvested RSUs and RSAs | 134,253 | 157,130 | 132,392
  > Convertible Notes (if-converted) | **85,945** | 89,379 | 89,379
  
  **2. Convertible Notes balances (Note 7, Debt)**
  
  > The Convertible Notes consisted of the following:
  >
  > As of December 31, | 2024 Principal | 2024 Unamortized Debt Issuance Costs | 2024 Net Carrying Amount | 2023 Principal | 2023 Unamortized Debt Issuance Costs | 2023 Net Carrying Amount
  > (in thousands) | | | | | |
  > 2025 Notes | $36,240 | $(28) | $36,212 | $284,105 | $(871) | $283,234
  > 2026 Notes | 249,754 | (624) | 249,130 | 838,482 | (3,402) | 835,080
  > 2027 Notes | 1,150,000 | (4,984) | 1,145,016 | 1,150,000 | (7,114) | 1,142,886
  > 2028 Notes | 1,500,000 | (8,982) | 1,491,018 | 1,500,000 | (11,800) | 1,488,200
  > 2030 Notes | 750,000 | (27,447) | 722,553 | — | — | —
  > Total | $3,685,994 | $(42,065) | $3,643,929 | $
  …[truncated 2,504 chars]

### Turn 5  (stop_reason=tool_use)
- submit_final_result({"final_result": "**Answer: about 85,945 thousand shares (≈85.95 million Class A shares) as of December 31, 2024.**\n\n**Basis.** Snap's FY2024 Form 10-K reports the if-converted dilutive effect of its convertible senior notes in its net loss per share note. The table of potentially dilutive shares excluded from diluted EPS lists <cite index=\"1-2\">Convertible Notes (if-converted)</cite> at 85,945 thousand shares for 2024 (89,379 for 2023 and 2022). Because the company had net losses, these shares were anti-dilutive and excluded from the diluted loss per share calculation. The filing does not itself state a \"maximum\" figure, so 85,945 thousand is the if-converted amount, which is the larg
…[truncated 1,429 chars])

### Final answer
**Answer: about 85,945 thousand shares (≈85.95 million Class A shares) as of December 31, 2024.**

**Basis.** Snap's FY2024 Form 10-K reports the if-converted dilutive effect of its convertible senior notes in its net loss per share note. The table of potentially dilutive shares excluded from diluted EPS lists <cite index="1-2">Convertible Notes (if-converted)</cite> at 85,945 thousand shares for 2024 (89,379 for 2023 and 2022). Because the company had net losses, these shares were anti-dilutive and excluded from the diluted loss per share calculation. The filing does not itself state a "maximum" figure, so 85,945 thousand is the if-converted amount, which is the largest dilution the notes can produce on a share-settled basis.

**Cross-check by series (my calculation: principal × conversion rate per $1,000).** Principal outstanding at 12/31/2024 and the initial conversion rates come from the debt note (Note 7):

| Series | Principal ($000) | Conversion rate per $1,000 | Implied shares (000) |
|---|---|---|---|
| 2025 Notes (0.25%) | 36,240 | 46.1233 | 1,671.51 |
| 2026 Notes (0.75%) | 249,754 | 43.8481 | 10,951.24 |
| 2027 Notes (no regular interest) | 1,150,000 | 11.2042 | 12,884.83 |
| 2028 Notes (0.125%) | 1,500,000 | 17.7494 | 26,624.10 |
| 2030 Notes (0.50%) | 750,000 | 45.0846 | 33,813.45 |
| **Total** | 3,685,994 | | **85,945.13** |

The sum reconciles to the 85,945 thousand shares in the filing. Conversion prices are about $21.68 (2025), $22.81 (2026), $89.25 (2027), $56.34 (2028) and $22.18 (2030).

**Context.** The notes may be settled in cash, Class A shares, or a combination at Snap's election, so the share count is a ceiling rather than an expected issuance. As of 12/31/2024, the if-converted value did not exceed principal, and the capped call transactions were out of the money.

Sources:
{
    "sources": [
        {
            "url": "https://www.sec.gov/Archives/edgar/data/1564408/000156440825000019/snap-20241231.htm",
            "name": "Snap Inc. Form 10-K for fiscal year ended December 31, 2024"
        }
    ]
}